David P. Nunes, MD, FRCPI
Associate Professor
Boston University School of Medicine
Dept of Medicine
Gastroenterology

MBBCh, Trinity College Dublin




Expertise includes: Clinical liver disease - interest in viral hepatitis; Evaluation and management of liver lesions.

Member
Boston University
Evans Center for Interdisciplinary Biomedical Research




A Phase 4, Randomized, Open-label, Active-Controlled, Superiority Study to Evaluate the Efficacy and Safety of Tenofovir Disoproxil Fumarate (TDF) in Combination with Peginterferon alpha-2a (Pegasys)
11/01/2011 - 12/31/2014 (PI)
Gilead Sciences, Inc.


A Phase 4, Randomized, Open-label, Active-Controlled, Superiority Study to Evaluate the Efficacy and Safety of Tenofovir Disoproxil Fumarate (TDF) in Combination with Peginterferon alpha-2a (Pegasys)
11/01/2011 - 12/31/2014 (PI)
Gilead Sciences, Inc.


A Study to Describe the Safety and Antiviral Effect of Entecavir (ETV) in Blacks/African Americans and Hispanics with Chronic Hepatitis B Virus (HBV) Infection who are Nucleoside-Naive
10/17/2006 - 10/16/2008 (PI)
Bristol-Myers Squibb

A Randomized, Placebo Controlled, Phase 1b Trial to Evaluate the Safety and Pharmacokinetics of NOV-205 in Chronic Viral Hepatitis C Subjects (Genotype 1) who have failed Treatment with Pegylated Interferon plus Ribavirin
01/23/2007 - 01/22/2008 (PI)
Novelos Therapeutics, Inc.

Phase II Study Of Long Term Peg Intron Fpr Patients Who Have Failed to Respond to Rebetron/Interferon with Advanced Fibrosis and Cirrhosis Secondary to Hepatitis C.
05/11/2001 - 05/31/2005 (PI)
Schering Corporation

Evaluating the Erythropoietic Response to Anemia in HCV
01/01/2002 - 12/31/2003 (PI)
Ortho Biotech Inc

Comparison of PEG Interferon Alfa 2b Plus Ribavirin Given as a Fixed Dose or on a Weight Optimized Basis for Treatment of Chronic Hepatitis C in Previously Untreated Adult Subjects
12/01/2001 - 11/30/2003 (PI)
Integrated Therapeutics Group

A Prospective, Randomized, Multicenter, Open Label Comparative Safety Study of Pegasys vs. Pegasys Plus Ribavirin Treatment vs. a Twelve Treatment Delay in Patients with Chronic Hepatitis C
02/06/2001 - 12/31/2002 (PI)
Roche Laboratories Inc

A Randomized, Partially Blinded, Multicenter, Phase II Study Investigating the Efficacy and Safety of Pegasys and Pegasys with Ribavirin in Treatment Naive Patients with Chronic Hepatitis C Coinfected with Human Immunodeficiency Virus
01/18/2001 - 01/31/2002 (PI)
Roche Laboratories Inc



Title


Yr Title Project-Sub Proj Pubs

Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.

iCite Analysis       Copy PMIDs To Clipboard

  1. Bhat S, Nunes D. Pharmacist-Managed Helicobacter pylori Treatment Service Within a Gastroenterology Clinic: Workflow and Real-World Experiences. Ann Pharmacother. 2021 May 28; 10600280211021501. PMID: 34049441
     
  2. Fuster D, Nunes D, Cheng DM, Saitz R, Samet JH. Alcohol Consumption and Hepatitis C Virus (HCV) RNA Levels in HIV/HCV Coinfected Patients. Viruses. 2021 04 21; 13(5).View Related Profiles. PMID: 33919027; PMCID: PMC8142976; DOI: 10.3390/v13050716;
     
  3. De La Cruz M, Nunes DP, Bhardwaj V, Subramanyan D, Zaworski C, Roy P, Roy HK. Colonic Epithelial Angiotensin-Converting Enzyme 2 (ACE2) Expression in Blacks and Whites: Potential Implications for Pathogenesis Covid-19 Racial Disparities. J Racial Ethn Health Disparities. 2021 Mar 10.View Related Profiles. PMID: 33694125; PMCID: PMC7945617; DOI: 10.1007/s40615-021-01004-9;
     
  4. Mohanty A, Eshein A, Kamineni P, Avissar U, Bliss CM, Long MT, Lowe RC, Moore TC, Nunes DP, Backman V, Roy HK. Quantification of gastric mucosal microcirculation as a surrogate marker of portal hypertension by spatially resolved subdiffuse reflectance spectroscopy in diagnosis of cirrhosis: a proof-of-concept study. Gastrointest Endosc. 2021 07; 94(1):60-67.e1.View Related Profiles. PMID: 33385462
     
  5. Gilad A, Fricker ZP, Hsieh A, Thomas DD, Zahorian T, Nunes DP. Sustained Improvement in Type 2 Diabetes Mellitus is Common After Treatment of Hepatitis C Virus With Direct-acting Antiviral Therapy. J Clin Gastroenterol. 2019 09; 53(8):616-620.View Related Profiles. PMID: 30614943
     
  6. Pratt PK, Nunes D, Long MT, Farraye FA. Improved Antibody Response to Three Additional Hepatitis B Vaccine Doses Following Primary Vaccination Failure in Patients with Inflammatory Bowel Disease. Dig Dis Sci. 2019 07; 64(7):2031-2038.View Related Profiles. PMID: 30945037; PMCID: PMC6764090; DOI: 10.1007/s10620-019-05595-6;
     
  7. Tran AN, Sachdev R, Fricker ZP, Leber M, Zahorian T, Shah B, Nunes DP, Long MT. Intensive Pharmacy Care Improves Outcomes of Hepatitis C Treatment in a Vulnerable Patient Population at a Safety-Net Hospital. Dig Dis Sci. 2018 12; 63(12):3241-3249.View Related Profiles. PMID: 30078116; PMCID: PMC6770976; DOI: 10.1007/s10620-018-5231-0;
     
  8. Kalman RS, Stawarz A, Nunes D, Zhang D, Dela Cruz MA, Mohanty A, Subramanian H, Backman V, Roy HK. Correction: Biophotonic detection of high order chromatin alterations in field carcinogenesis predicts risk of future hepatocellular carcinoma: A pilot study. PLoS One. 2018; 13(7):e0201500.View Related Profiles. PMID: 30040862; PMCID: PMC6057665; DOI: 10.1371/journal.pone.0201500;
     
  9. Kalman R, Stawarz A, Nunes D, Zhang D, Dela Cruz MA, Mohanty A, Subramanian H, Backman V, Roy HK. Biophotonic detection of high order chromatin alterations in field carcinogenesis predicts risk of future hepatocellular carcinoma: A pilot study. PLoS One. 2018; 13(5):e0197427.View Related Profiles. PMID: 29771950; PMCID: PMC5957523; DOI: 10.1371/journal.pone.0197427;
     
  10. Reddy YNV, Nunes D, Chitalia V, Gordon CE, Francis JM. Hepatitis C virus infection in kidney transplantation-changing paradigms with novel agents. Hemodial Int. 2018 04; 22 Suppl 1:S53-S60.View Related Profiles. PMID: 29694721; PMCID: PMC6815878; DOI: 10.1111/hdi.12659;
     
Showing 10 of 62 results. Show More

This graph shows the total number of publications by year, by first, middle/unknown, or last author.

Bar chart showing 62 publications over 23 distinct years, with a maximum of 5 publications in 2007

YearPublications
19892
19921
19953
19961
19974
19984
19993
20004
20022
20031
20043
20054
20063
20075
20084
20101
20111
20134
20152
20184
20192
20201
20213

In addition to these self-described keywords below, a list of MeSH based concepts is available here.

Hepatitis B
Hepatitis C
Liver fibrosis
Contact for Mentoring:

85 E. Concord St
Boston MA 02118
Google Map


Nunes's Networks
Click the "See All" links for more information and interactive visualizations
Concepts
_
Co-Authors
_
Similar People
_
Same Department